New Agents for Acute Treatment of Migraine in Adults

New Agents for Acute Treatment of Migraine in Adults

January 5th, 2021 | Pharmacy PearlsMigraine

This edition of Pharmacy Pearls reviews the new agents that have been approved for acute migraine treatment and covers important clinical information including mechanism of action, efficacy data, common drug interactions, and cost. As most available clinical trials compare these agents to placebo (not currently available therapies), we also review potential role in therapy for these new agents.

As always, we welcome any questions or feedback you may have. Just email the Pharmacy Team.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download PDF [234.33 KB]